Enantioenriched three-dimensional (3D) fluorinated scaffolds are pivotal in drug discovery, whereas the asymmetric synthesis directly from readily available 2D fluoroalkenes represents a desirable yet challenging synthetic objective. The α-carbon of gem-difluoroalkenes is inherently electrophilic, which typically precludes their utility in nucleophilic assemblies. Herein, we report an umpolung strategy that utilizes low-valent Ni(0) as a π-Lewis base activator for gem-difluorodienes and leverages d → π* backdonation to effectively reverse their intrinsic electrophilicity, thereby enabling the addition to aldehydes and imines stereoselectively. Two distinct transformative pathways for the resultant difluoro π-allylnickel(II) species are developed: exclusively (Z)-defined defluorination and reductive coupling, finally furnishing chiral fluoroalkenyl and gem-difluoro homoallylic derivatives, respectively. In addition, stereodivergent control over vicinal fluorine-containing stereocenters is achievable under the identical catalysis, by simply using geometric isomers of 1-fluorodienes. The current Ni(0)-based umpolung paradigm of fluorodienes establishes a powerful framework for constructing structurally diverse and enantioenriched fluorinated compounds with pharmaceutical significance.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: